Koh et al. [31] also reported that TUBB3-positive patients showed lower response rates, and that the PFS and OS times were shorter in patients with head and neck squamous cell carcinoma receiving induction chemotherapy. Here, TUBB3 is linked to head and neck squamous cell carcinoma.